126 related articles for article (PubMed ID: 14583188)
21. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Tranter HS; Acharya KR
J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
[TBL] [Abstract][Full Text] [Related]
23. Superantigen-induced lysis of melanoma cells.
Krull F; Holzer U; Ihle J; Bethge W; Fierlbeck G; Kalland T; Dohlsten M; Niethammer D; Dannecker GE
Melanoma Res; 1997 Jun; 7(3):214-22. PubMed ID: 9195560
[TBL] [Abstract][Full Text] [Related]
24. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
25. Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model.
Boehncke WH; Hardt-Weinelt K; Nilsson H; Wolter M; Dohlsten M; Ochsendorf FR; Kaufmann R; Antonsson P
J Invest Dermatol; 2001 Apr; 116(4):596-601. PubMed ID: 11286628
[TBL] [Abstract][Full Text] [Related]
26. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
[TBL] [Abstract][Full Text] [Related]
27. The superantigen staphylococcal enterotoxin A (SEA) and monoclonal antibody L243 share a common epitope but differ in their ability to induce apoptosis via MHC-II.
Gross U; Schroder AK; Haylett RS; Arlt S; Rink L
Immunobiology; 2006; 211(10):807-14. PubMed ID: 17113918
[TBL] [Abstract][Full Text] [Related]
28. Immune response during tumor therapy with antibody-superantigen fusion proteins.
Rosendahl A; Hansson J; Sundstedt A; Kalland T; Dohlsten M
Int J Cancer; 1996 Sep; 68(1):109-13. PubMed ID: 8895549
[TBL] [Abstract][Full Text] [Related]
29. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
30. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
[TBL] [Abstract][Full Text] [Related]
31. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
Nilsson H; Björk P; Dohlsten M; Antonsson P
J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
[TBL] [Abstract][Full Text] [Related]
32. Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR.
Antonsson P; Wingren AG; Hansson J; Kalland T; Varga M; Dohlsten M
J Immunol; 1997 May; 158(9):4245-51. PubMed ID: 9126986
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma.
Nielsen SE; Zeuthen J; Lund B; Persson B; Alenfall J; Hansen HH
J Immunother; 2000 Jan; 23(1):146-53. PubMed ID: 10687147
[TBL] [Abstract][Full Text] [Related]
34. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
Tiedemann RE; Fraser JD
J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
[TBL] [Abstract][Full Text] [Related]
35. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
[TBL] [Abstract][Full Text] [Related]
36. Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.
Dohlsten M; Hansson J; Ohlsson L; Litton M; Kalland T
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9791-5. PubMed ID: 7568219
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.
Hamad AR; Herman A; Marrack P; Kappler JW
J Exp Med; 1994 Aug; 180(2):615-21. PubMed ID: 7519243
[TBL] [Abstract][Full Text] [Related]
38. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
Torres BA; Griggs ND; Johnson HM
Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
[TBL] [Abstract][Full Text] [Related]
39. Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity.
Mollick JA; McMasters RL; Grossman D; Rich RR
J Exp Med; 1993 Feb; 177(2):283-93. PubMed ID: 7678849
[TBL] [Abstract][Full Text] [Related]
40. Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer.
Giantonio BJ; Alpaugh RK; Schultz J; McAleer C; Newton DW; Shannon B; Guedez Y; Kotb M; Vitek L; Persson R; Gunnarsson PO; Kalland T; Dohlsten M; Persson B; Weiner LM
J Clin Oncol; 1997 May; 15(5):1994-2007. PubMed ID: 9164211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]